Copyright
©The Author(s) 2017.
World J Gastrointest Pharmacol Ther. Aug 6, 2017; 8(3): 155-161
Published online Aug 6, 2017. doi: 10.4292/wjgpt.v8.i3.155
Published online Aug 6, 2017. doi: 10.4292/wjgpt.v8.i3.155
Table 2 A total of twelve patients on either infliximab or adalimumab were included in the case serie
Patient | Age (yr) | Sex | Diagnosis | Montreal classification | Duration of disease (yr) | Previous anti-TNF therapy? | Immunomodulator therapy? |
1 | 24 | M | CD | A2L3B1 | 5 | Y | Previous - MTX |
2 | 46 | M | UC | E3 | 10 | N | Previous - 6MP |
3 | 71 | M | CD | A3L1B2 | 4 | N | Previous - 6MP |
4 | 31 | F | CD | A2L1B2 | 9 | Y | Current - 6MP |
5 | 46 | F | CD | A2L3B2p | 5 | N | None |
6 | 41 | M | UC | E2 | 18 | N | Current - AZA |
7 | 53 | F | UC | E2 | 24 | Y | Previous - MTX |
8 | 21 | M | UC | E3 | 1 | N | Current - MTX |
9 | 67 | M | CD | A3L2B1 | 3 | N | None |
10 | 26 | M | CD | A1L2B1 | 11 | N | None |
11 | 49 | F | CD | A2L3B2 | 30 | N | None |
12 | 25 | M | CD | A2L1B2 | 7 | Y | Current - MTX |
- Citation: Kothari MM, Nguyen DL, Parekh NK. Strategies for overcoming anti-tumor necrosis factor drug antibodies in inflammatory bowel disease: Case series and review of literature. World J Gastrointest Pharmacol Ther 2017; 8(3): 155-161
- URL: https://www.wjgnet.com/2150-5349/full/v8/i3/155.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v8.i3.155